0001214659-22-000265.txt : 20220104 0001214659-22-000265.hdr.sgml : 20220104 20220104182030 ACCESSION NUMBER: 0001214659-22-000265 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220104 DATE AS OF CHANGE: 20220104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MORRIS TIMOTHY E CENTRAL INDEX KEY: 0001191286 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35798 FILM NUMBER: 22508252 MAIL ADDRESS: STREET 1: ACELRX PHARMACEUTICALS, INC. STREET 2: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANIGEN, INC CENTRAL INDEX KEY: 0001293310 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770557236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650.243.3100 MAIL ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20040609 4 1 marketforms-54935.xml PRIMARY DOCUMENT X0306 4 2021-12-31 0001293310 HUMANIGEN, INC HGEN 0001191286 MORRIS TIMOTHY E C/O HUMANIGEN, INC. 533 AIRPORT BOULEVARD, SUITE 400 BURLINGAME CA 94010 false true false false COO and CFO Stock Option (Right to Buy) 3.72 2021-12-31 4 A false 51000 0 A 2022-03-31 2031-12-30 Common Stock 51000 51000 D The option vests in 12 ratable quarterly installments commencing March 31, 2022. /s/ Timothy Morris 2022-01-04